Aligos Therapeutics, Inc. (ALGS)
2.15
-0.42
(-16.34%)
USD |
NASDAQ |
Nov 11, 16:00
2.09
-0.06
(-2.79%)
After-Hours: 19:59
Aligos Therapeutics EPS Diluted (Quarterly) : -2.090 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -2.090 |
| June 30, 2026 | -0.1442 |
| March 31, 2026 | -2.215 |
| December 31, 2025 | -1.915 |
| September 30, 2025 | -3.041 |
| June 30, 2025 | -1.532 |
| March 31, 2025 | -2.113 |
| December 31, 2024 | -13.08 |
| September 30, 2024 | -3.070 |
| June 30, 2024 | 0.8078 |
| March 31, 2024 | -5.582 |
| December 31, 2023 | -5.502 |
| September 30, 2023 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 0.0183 |
| Amgen, Inc. | 7.077 |
| Anika Therapeutics, Inc. | -0.0232 |
| BioCryst Pharmaceuticals, Inc. | 0.1417 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.86M |
| Revenue (Quarterly) | 2.869M |
| Total Expenses (Quarterly) | 24.73M |
| Enterprise Value | -3.781M |
| Gross Profit Margin (Quarterly) | 91.25% |
| Profit Margin (Quarterly) | -761.9% |
| Earnings Yield | -296.0% |
| Normalized Earnings Yield | -320.26 |